Skip to main content

. 1962 Oct 6;87(14):768–769.

Death due to Liver Failure Following the Use of Methandrostenolone

Edmund M Wilder

PMCID: PMC1849648 PMID: 14000685

768

Images in this article

Fig. 1
on p.769

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

KINTZEN W., SILNY J. Peliosis hepatis after administration of fluoxymesterone. Can Med Assoc J. 1960 Oct 15;83:860–862. [PMC free article] [PubMed] [Google Scholar]
KOSZALKA M. F. Medical obstructive jaundice; report of a death due to methyltestosterone. J Lancet. 1957 Feb;77(2):51–54. [PubMed] [Google Scholar]
LIDDLE G. W., BURKE H. A., Jr Anabolic steroids in clinical medicine. Helv Med Acta. 1960 Dec;27:504–513. [PubMed] [Google Scholar]
SCHAFFNER F., POPPER H., CHESROW E. Cholestasis produced by the administration of norethandrolone. Am J Med. 1959 Feb;26(2):249–254. doi: 10.1016/0002-9343(59)90314-6. [DOI] [PubMed] [Google Scholar]
STEIGMANN F. The early recognition of drug-induced liver disease. Med Clin North Am. 1960 Jan;44:183–192. doi: 10.1016/s0025-7125(16)34064-0. [DOI] [PubMed] [Google Scholar]
WYNN V., LANDON J., KAWERAU E. Studies of hepatic function during methandienone therapy. Lancet. 1961 Jan 14;1(7168):69–75. doi: 10.1016/s0140-6736(61)92118-3. [DOI] [PubMed] [Google Scholar]

ACTIONS

PDF (639.4 KB)

RESOURCES